Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1060737 | 0.92 | — | — | |
| SCHEMBL7330065 | 0.79 | MAPT (0.32) | — | |
| SCHEMBL11303875 | 0.76 | — | — | |
| SCHEMBL9189204 | 0.75 | MAPT (0.36) | SLC6A2SLC6A4OPRM1 | |
| SCHEMBL10680456 | 0.73 | SLC6A2 (0.33) | SLC6A2SLC6A4OPRM1 | |
| SCHEMBL3246813 | 0.73 | SLC6A4 (0.33) | SLC6A2SLC6A4OPRM1 | |
| SCHEMBL940127 | 0.73 | SLC6A4 (0.35) | SLC6A2SLC6A4OPRM1 | |
| SCHEMBL1081300 | 0.71 | MAPT (0.33) | — | |
| SCHEMBL1076375 | 0.71 | — | — | |
| SCHEMBL16933846 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546587-B2 | Method for producing acrylate derivative, acrylate derivative, and intermediate thereof | KURARAY CO., LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-8431722-B2 | Acrylate ester derivatives and polymer compounds | KURARAY CO., LTD. (JP) | 2013-04-30 | — | — | US | disclosed |
| US-8362169-B2 | Acrylate ester derivatives and polymer compounds | KURARAY CO., LTD. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20130005990-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | KURARAY CO., LTD. (JP) | 2013-01-03 | — | — | US | disclosed |
| US-20120316349-A1 | ACRYLATE ESTER DERIVATIVES AND POLYMER COMPOUNDS | KURARAY CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| US-8314258-B2 | Method for producing acrylate derivative, acrylate derivative, and intermediate thereof | KURARAY CO., LTD. (JP) | 2012-11-20 | — | — | US | disclosed |
| US-20110060112-A1 | ACRYLATE ESTER DERIVATIVES AND POLYMER COMPOUNDS | KURARAY CO., LTD. (JP) | 2011-03-10 | — | — | US | disclosed |
| US-20110009643-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | KURARAY CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005990-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | ACR, ADH1A, ALAD | SLC6A2 3770/4885SLC6A4 2101/4885OPRM1 3828/4885 |
| US-20120316349-A1 | ACRYLATE ESTER DERIVATIVES AND POLYMER COMPOUNDS | ADH1A, ADH1C, ADH5 | SLC6A2 4320/4885SLC6A4 3974/4885OPRM1 201/4885 |
| US-20110060112-A1 | ACRYLATE ESTER DERIVATIVES AND POLYMER COMPOUNDS | RAD51, LBR, RPLP0 | SLC6A2 4670/4885SLC6A4 3383/4885OPRM1 1535/4885 |
| US-20110009643-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | ACR, ADH1A, ALAD | SLC6A2 3770/4885SLC6A4 2101/4885OPRM1 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.